Research Article

Pathology of Hepatocellular Carcinoma and Tumor-Bearing Liver Tissue in Association with hTERT Promoter Mutation

Table 2

hTERT promoter mutation in hepatocellular carcinoma (HCC): general data and association with clinical and pathomorphological findings.

Number of cases with cirrhosis (absolute numbers and %)Number of cases without cirrhosis (absolute numbers and %)Total number (%)Comparative test

1Frequency of cirrhosis93 (58.1)67 (41.9)160
2hTERT promoter mutation71 (70.3)30 (29.7)101 (63.1)2 vs. 3<0.00
3Wildtype hTERT22 (37.3)37 (62.7)59 (36.9)
4Males with hTERT promoter mutation61 (73.5)22 (26.5)83 (63.4)
5Females with hTERT promoter mutation10 (55.6)8 (44.4)18 (62.1)
6 years with hTERT promoter mutation14 (56.0)3 (25.0)17 (45.9)6 vs. 70.01
7 years with hTERT promoter mutation57 (83.3)27 (49.1)84 (68.3)
8Alcoholic liver disease31 (71.5)13 (29.5)44 (27.5)
9Hepatitis C virus infection17 (73.9)6 (26.1)23 (14.3)
10Hepatitis B virus infection14 (76.5)5 (50.0)19 (11.9)
11G1 HCC with hTERT promoter mutation6 (50.0)4 (50.0)10 (50.0)11 vs. 13 cirrhosis0.02
12G2 HCC with hTERT promoter mutation48 (76.2)22 (45.8)70 (63.1)
13G3 HCC with hTERT promoter mutation17 (94.4)4 (36.4)21 (72.4)
14Conventional type with hTERT promoter mutation62 (75.6)12 (50.0)84 (71.2)
15Solid type with hTERT promoter mutation3 (100)10 (62.5)13 (68.4)
16Steatohepatitic type with hTERT promoter mutation5 (88.3)5 (50.0)10 (62.5)
17Tumor size (cm); hTERT promoter mutation (cm)3.9 cm6.2 cm17 cirrhosis vs. non-cirrhosis0.01
18Tumor size (cm) wildtype (cm)3.9 cm7.7 cm18 cirrhosis vs. non-cirrhosis<0.00

Chi square test. Fisher’s exact test.